A combination treatment may improve survival in patients with both pulmonary hypertension and pulmonary fibrosis, a study ...

Reducing the levels of the protein NEK2 in the pulmonary arteries may reverse vascular remodeling in PAH, a rat study showed.

Synhale has acquired telaglenastat, and is planning a Phase 2 clinical trial testing the therapy in patients with pulmonary ...

There are night owls and morning larks, writes columnist Colleen Steele, referring to people's sleep habits. So which bird are you?